National Cancer Institute

FY 2017 Research Funding by Cancer Type

Cancer Type Funded Amount
Anus $6,125,967
Bladder $35,665,315
Brain $216,979,499
Breast $545,149,951
Buccal Cavity $15,108,336
Central Nervous System - Not Including Brain $2,779,293
Cervical Cancer $67,965,454
Childhood Leukemia $62,906,339
Colon/Rectum $208,406,608
Esophagus $31,843,910
Eye $8,571,228
Gallbladder $3,638,033
Head and Neck $63,647,517
Heart $1,049,071
Hodgkins disease $13,018,548
Kaposi Sarcoma $31,195,995
Kidney Cancer $45,596,811
Kidney Disease $47,723,327
Larynx $634,261
Leukemia $250,547,507
Liver Cancer $72,721,830
Lung $320,564,352
Melanoma $153,176,356
Multiple Myeloma $60,746,955
Nervous System $33,640,923
Neuroblastoma $23,594,430
Non Hodgkins Lymphoma $119,514,716
Ovarian Cancer $109,786,028
Pancreas $178,331,745
Parathyroid $1,101,925
Penis $651,482
Pharynx $3,446,471
Pituitary $1,596,179
Prostate $233,034,406
Salivary Glands $678,015
Sarcoma $85,426,697
Stomach $13,372,820
Testes $2,876,459
Thyroid $22,767,173
Urinary System $17,681,275
Uterine $17,505,925
Vaginal $912,103
Vascular Disease $1,987,916
Wilm's Tumor $4,673,401